ScholarIQanswers from OpenAlex
Universidad San Carlos
InstitutionResearch output, impact & collaborations
Universidad San Carlos is a institution indexed in ScholarIQ from OpenAlex.
What is known about Universidad San Carlos?
ScholarIQrecord summary
Universidad San Carlos is a research organisation in Asunción, PY. OpenAlex records 1,374 works and 23,008 citations for it. 709 researchers list it as their most recent affiliation.
How many works does Universidad San Carlos have?
ScholarIQindexed works
Universidad San Carlos has 1,374 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Universidad San Carlos have?
ScholarIQcitation count
Universidad San Carlos has 23,008 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Universidad San Carlos?
ScholarIQresearcher count
Universidad San Carlos has 709 researchers in the ScholarIQ index.
What is the average h-index at Universidad San Carlos?
ScholarIQavg h-index
Universidad San Carlos has an average h-index of 47 in OpenAlex.
What is the ROR of Universidad San Carlos?
ScholarIQror
The ROR for Universidad San Carlos is on the source record.
What is the OpenAlex record for Universidad San Carlos?
ScholarIQopenalex
The OpenAlex for Universidad San Carlos is on the source record.
Who are the most-cited researchers behind Universidad San Carlos?
ScholarIQtop researchers by citations
What are the most-cited papers on Universidad San Carlos?
ScholarIQmost cited works
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
William Pao, Vincent A. Miller, Maureen F. Zakowski, Jennifer A. Doherty, Katerina Politi, Inderpal S. Sarkaria, Bhuvanesh Singh, Robert T. Heelan, Valerie W. Rusch, Lucinda A. Fulton, Elaine R. Mardis, Doris M. Kupfer, Richard K. Wilson, Mark G. Kris, Harold Varmus
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers, Caitlin Connelly, David Fabrizio, Laurie M. Gay, Siraj M. Ali, Riley Ennis, Alexa B. Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin W. Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi A. Garraway, Vincent A. Miller, P. J. Stephens, Garrett M. Frampton
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
William Pao, Vincent A. Miller, Katerina Politi, Gregory J. Riely, Romel Somwar, Maureen F. Zakowski, Mark G. Kris, Harold Varmus
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with <i>EGFR</i> -Mutant Lung Cancers
Helena A. Yu, Maria E. Arcila, Natasha Rekhtman, Camelia S. Sima, Maureen F. Zakowski, William Pao, Mark G. Kris, Vincent A. Miller, Marc Ladanyi, Gregory J. Riely
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
How much of the research on Universidad San Carlos is open access?
ScholarIQopen access share
83%OPEN ACCESS